Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 10, 2011, Pages 1322-1329

  Blank, S ^a   Seismann, H ^a   Michel, Y ^a   McIntyre, M ^b   Cifuentes, L ^b   Braren, I ^c   Grunwald, T ^d   Darsow, U ^b,e   Ring, J ^b,e   Bredehorst, R ^a   Ollert, M ^b   Spillner, E ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d PLS Design GmbH   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Api m 10; cross reactive carbohydrate determinant; insect venom allergy; recombinant allergens; venom preparation

Indexed keywords

ALLERGEN; API M 10; BEE VENOM; CROSS REACTING ANTIBODY; GLYCOSYLATED PROTEIN; HYMENOPTERA VENOM; IMMUNOGLOBULIN E ANTIBODY; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ARTICLE; BASOPHIL; CELL ACTIVATION; CONTROLLED STUDY; CROSS ALLERGY; ESCHERICHIA COLI; FUCOSYLATION; GLYCOSYLATION; HONEYBEE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOTHERAPY; INSECT CELL; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL;

ALLERGENS; ANIMALS; BASOPHILS; BEE VENOMS; BEES; CROSS REACTIONS; HUMANS; IMMUNOGLOBULIN E; INSECT BITES AND STINGS; RECOMBINANT PROTEINS;

EID: 80052680684     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02667.x     Document Type: Article

References (20)

1. Muller U, Helbling A, Berchtold E,. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992; 89: 529-535.
2. Rueff F, Przybilla B, Muller U, Mosbech H,. The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 1996; 51: 216-225. (Pubitemid 126439560)
3. Arbesman CE, Reisman RE, Wypych JI,. Allergenic potency of bee antigens measured by RAST inhibition. Clin Allergy 1976; 6: 587-595.
4. Müller UR,. Insektenstichallergie: Klinik, Diagnostik und Therapie. Stuttgart, New York: Gustav Fischer Verlag, 1988.
5. Grunwald T, Bockisch B, Spillner E, Ring J, Bredehorst R, Ollert MW,. Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3). J Allergy Clin Immunol 2006; 117: 848-854.
6. Blank S, Seismann H, Bockisch B, Braren I, Cifuentes L, McIntyre M, et al., Identification, recombinant expression, and characterization of the 100 kDa high molecular weight hymenoptera venom allergens Api m 5 and Ves v 3. J Immunol 2010; 184: 5403-5413.
7. Soldatova LN, Crameri R, Gmachl M, Kemeny DM, Schmidt M, Weber M, et al., Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J Allergy Clin Immunol 1998; 101: 691-698. (Pubitemid 28228315)
8. Aalberse RC, Akkerdaas J, van Ree R,. Cross-reactivity of IgE antibodies to allergens. Allergy 2001; 56: 478-490. (Pubitemid 32521427)
9. Hemmer W, Focke M, Kolarich D, Dalik I, Gotz M, Jarisch R,. Identification by immunoblot of venom glycoproteins displaying immunoglobulin E-binding N-glycans as cross-reactive allergens in honeybee and yellow jacket venom. Clin Exp Allergy 2004; 34: 460-469. (Pubitemid 38373011)
10. Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hubsch-Muller C, Enk A,. In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy 2006; 61: 1220-1229. (Pubitemid 44326360)
11. Schmidt M, Weimer ET, Sakell RH, Hoffman DR,. Proteins in the high molecular weight fraction of honeybee venom. J Allergy Clin Immunol 2005; 115: S107.
12. Peiren N, Vanrobaeys F, de Graaf DC, Devreese B, Van Beeumen J, Jacobs FJ,. The protein composition of honeybee venom reconsidered by a proteomic approach. Biochim Biophys Acta 2005; 1752: 1-5. (Pubitemid 41207243)
13. Peiren N, de Graaf DC, Brunain M, Bridts CH, Ebo DG, Stevens WJ, et al., Molecular cloning and expression of icarapin, a novel IgE-binding bee venom protein. FEBS Lett 2006; 580: 4895-4899. (Pubitemid 44286852)
14. Eberlein-Konig B, Schmidt-Leidescher C, Rakoski J, Behrendt H, Ring J,. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. J Investig Allergol Clin Immunol 2006; 16: 5-10.
15. Ausubel FM,. Current Protocols in Molecular Biology. New York: Wiley Interscience, 1996.
16. Braren I, Blank S, Seismann H, Deckers S, Ollert M, Grunwald T, et al., Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries. Clin Chem 2007; 53: 837-844. (Pubitemid 46744238)
17. Southworth MW, Amaya K, Evans TC, Xu MQ, Perler FB,. Purification of proteins fused to either the amino or carboxy terminus of the Mycobacterium xenopi gyrase A intein. BioTechniques 1999; 116: 118-120.
18. Seismann H, Blank S, Braren I, Greunke K, Cifuentes L, Grunwald T, et al., Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of alpha-1,3-core fucosylation. Mol Immunol 2010; 47: 799-808.
19. Aalberse RC, van der Gaag R, van Leeuwen J,. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983; 130: 722-726. (Pubitemid 13186294)
20. Habermann E,. Bee and wasp venoms. Science 1972; 177: 314-322.